The identity of the physiological metal cofactor for human methionine aminopeptidase-2(MetAP2) has not been established. To examine this question, we first investigated the effect of eightdivalent metal ions, including Ca
2+, Co
2+, Cu
2+, Fe
2+, Mg
2+, Mn
2+, Ni
2+, and Zn
2+, on recombinanthuman methionine aminopeptidase apoenzymes in releasing N-terminal methionine from three peptidesubstrates: MAS, MGAQFSKT, and
3H-MASK(biotin)G. The activity of MetAP2 on either MAS orMGAQFSKT was enhanced 15-25-fold by Co
2+ or Mn
2+ metal ions in a broad concentration range(1-1000
M). In the presence of reduced glutathione to mimic the cellular environment, Co
2+ and Mn
2+were also the best stimulators (~30-fold) for MetAP2 enzyme activity. To determine which metal ion isphysiologically relevant, we then tested inhibition of intracellular MetAP2 with synthetic inhibitors selectivefor MetAP2 with different metal cofactors. A-310840 below 10
M did not inhibit the activity of MetAP2-Mn
2+ but was very potent against MetAP2 with other metal ions including Co
2+, Fe
2+, Ni
2+, and Zn
2+ inthe in vitro enzyme assays. In contrast, A-311263 inhibited MetAP2 with Mn
2+, as well as Co
2+, Fe
2+,Ni
2+, and Zn
2+. In cell culture assays, A-310840 did not inhibit intracellular MetAP2 enzyme activityand did not inhibit cell proliferation despite its ability to permeate and accumulate in cytosol, whileA-311263 inhibited both intracellular MetAP2 and proliferation in a similar concentration range, indicatingcellular MetAP2 is functioning as a manganese enzyme but not as a cobalt, zinc, iron, or nickel enzyme.We conclude that MetAP2 is a manganese enzyme and that therapeutic MetAP2 inhibitors should inhibitMetAP2-Mn
2+.